This is the clinical companion to our personal-story pregnancy piece. It summarises the guideline position, the practical protocol, and the postpartum window most quit plans forget about. Nothing here replaces advice from your obstetric clinician; if anything conflicts with what they have told you, follow them.

What the evidence says about nicotine in pregnancy

Nicotine crosses the placenta and reaches fetal blood at levels comparable to maternal levels. It affects:

  • Fetal brain development, particularly nicotinic receptor systems that influence attention and impulse control
  • Fetal lung development, contributing to reduced lung function and higher asthma risk
  • Placental blood flow, with dose-related effects on birth weight

Vapour also contains other constituents (flavourings, PG/VG, trace metals) whose long-term reproductive effects are less well characterised. The absence of combustion is a real difference from cigarettes, but "safer than smoking" is not the same as "safe in pregnancy," and no major guideline treats it as such.

The first-line: behavioural support

Every major body (ACOG, RCOG, NHS, CDC) recommends starting with behavioural support:

  1. Set a quit date within one to two weeks of the appointment.
  2. Enrol in a quitline with a specific pregnancy pathway. UK Stop Smoking Services allocate a specialist midwife; US state quitlines have dedicated pregnancy protocols.
  3. Consider a quit-vaping app for daily accountability, breathing exercises, and craving logging.

The trials in pregnancy show clear benefit from behavioural support alone in a meaningful minority of participants.

When NRT is considered

If behavioural approaches alone do not work in a reasonable window (usually 2-4 weeks) and continued vaping is the alternative, an obstetric clinician may add NRT. Key points from the guidelines:

  • Intermittent forms preferred. Gum, lozenges, spray. Avoids continuous 24-hour exposure.
  • Lowest effective dose. Titrated to just enough to control cravings.
  • Removed as soon as feasible. Not a long-term plan.
  • Never in combination with continued vaping.

The Cochrane review of NRT in pregnancy finds modest benefit; individual risk-benefit is made with a clinician who knows the pregnancy.

Medications generally avoided

Varenicline and bupropion are usually avoided in pregnancy due to limited safety data. In rare, complex cases they may be considered under specialist care.

Trimester-specific notes

  • First trimester. Highest impact of quitting; also often the trimester of nausea, which can make gum and lozenges harder. Patches are considered case-by-case.
  • Second trimester. Symptoms usually settle; a strong window for behavioural quitting.
  • Third trimester. Any reduction still helps; late quitters see benefits in birth outcomes and infant respiratory health.

Breastfeeding

Nicotine passes into breast milk with a half-life similar to blood nicotine (roughly two hours). Recommendations vary; the general approach is:

  • Full cessation is preferred.
  • If any NRT is used, intermittent forms are timed so blood nicotine is lowest at the next feed.
  • Breastfeeding remains preferred to formula even if some nicotine exposure persists; discuss the specifics with a pediatrician.

The postpartum relapse window

Roughly half of pregnancy quitters relapse within the first year postpartum, with a peak between 6 and 12 weeks after delivery. Sleep deprivation, hormonal shifts, and the removal of "I am doing this for the baby" as the frame all contribute.

A postpartum plan built during pregnancy is more effective than one built after delivery:

  1. Identify the specific postpartum triggers you expect (night feeds, first return to social settings, first solo drive).
  2. Line up a partner or coach for check-ins at week 6.
  3. Keep the app and quit tools installed and active postpartum.
  4. Plan re-engagement with the quitline or clinician if craving pressure rises.

Our relapse recovery pillar covers the general slip-recovery protocol, which applies unchanged in postpartum.

Making it stick

Pregnancy is a high-stakes, high-motivation quit window. The evidence-based path is not different from the general one — behavioural support first, NRT if needed under clinician care, plan for postpartum — but the stakes make careful planning worth it.

For a lived-experience walkthrough of a real quit during pregnancy, see our companion story.